BIOE: the cash flow

MyFinsight

For the quarter ending 2025-09-30, BIOE had $28,741 increase in cash & cash equivalents over the period.

Cash Flow	2025-09-30	2025-06-30
Net loss from continuing operations (include gain on disposal of subsidiary)	12,998	-145,888
Depreciation and amortization expense	58	118
Operating lease expense	9,400	25,346
Accounts receivable	0	-155
Prepaid expenses and other receivables	-2	-187,794
Prepayment and deposits	43,161	21,104
Accounts payable	-85	-7,046
Customer deposit	539,360	103,164
Tax payable	-810	494
Accrued liability and other payables	-336,302	-
Other current liability	5,513	-1,305
Loss on disposal of fixed assets	0	0
Gain from disposal of discontinued operations	0	0
Impairment loss of rou asset	0	-
Receivable from sale of bep	0	-
Accrued interest	0	0
Payment of lease liability	0	0
Net cash provided by operating activities from continuing operations	186,973	141,728
Net cash used in operating activities from discontinued operations	0	0
Net cash provided by operating activities	186,973	141,728
Loan from shareholder	224,050	419,400
Repayment to shareholder	-375,000	-568,800
Repayment of sba loan	316	665
Change in bank overdraft	-6,966	6,966
Net cash used in financing activities from continuing operations	-158,232	-143,099
Net cash used in financing activities from discontinued operations	0	0
Net cash used in financing activities	-158,232	-143,099
Net increase in cash	28,741	-1,371
Cash and cash equivalents at beginning of period	1,371	-
Cash and cash equivalents at end of period	28,741	-

Unit: Dollar. Numbers labeled with * are estimated quarterly values.